Latest filing published 15 May 2020 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €4.3M.
All filings by John Paulson on record concern Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). In total, 12 filings cover trades dated from 12 May 2020 to 14 May 2020.
The open-market record is one-sided, with 12 purchases worth €54.6M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €5.2M. The 12 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 15 May 2020 with an open-market purchase (€4.3M) in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 2 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations